Adaptive Biotechnologies Corporation
NASDAQ: ADPT0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Global Select
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Chad Robins
- Employees
- 619
- Headquarters
- Seattle, United States
- IPO year
- 2019
- Market cap
- $3.1B
- Website
- https://www.adaptivebiotech.com
Loading ADPT…
Loading profile data…Frequently asked questions about ADPT
What does Adaptive Biotechnologies Corporation (ADPT) do?
Adaptive Biotechnologies Corporation, founded in 2009 and headquartered in Seattle, Washington (operating as Adaptive TCR Corporation until its name change in December 2011), is a commercial-stage entity focused on pioneering an immune medicine platform. This advanced platform is engineered for the precise diagnosis and effective treatment of a...
Where does ADPT trade?
Adaptive Biotechnologies Corporation (ADPT) trades on the NASDAQ Global Select.
What sector is ADPT in?
Adaptive Biotechnologies Corporation (ADPT) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Adaptive Biotechnologies Corporation?
Chad Robins is the chief executive officer of Adaptive Biotechnologies Corporation (ADPT).
Where is Adaptive Biotechnologies Corporation headquartered?
Adaptive Biotechnologies Corporation is headquartered in United States.
Does ADPT pay a dividend?
Adaptive Biotechnologies Corporation (ADPT) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did ADPT go public?
Adaptive Biotechnologies Corporation (ADPT) completed its initial public offering in 2019.